Helix BioPharma (TSE:HBP)
TSX:HBP

Helix BioPharma (HBP) Financial Statements

24 Followers

Helix BioPharma Financial Overview

Helix BioPharma's market cap is currently ―. The company's EPS TTM is C$-0.029; its P/E ratio is -7.77; Helix BioPharma is scheduled to report earnings on October 25, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Apr 24Jan 24Oct 23Jul 23Apr 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -1.83MC$ -880.00KC$ -1.25MC$ -2.16MC$ -1.33M
EBITDAC$ -1.82MC$ -877.00KC$ -1.25MC$ -2.16MC$ -1.33M
Net Income Common StockholdersC$ -1.83MC$ -902.00KC$ -1.25MC$ -2.16MC$ -1.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 710.00KC$ 120.00KC$ 1.64MC$ 808.00KC$ 1.33M
Total AssetsC$ 1.15MC$ 343.00KC$ 1.90MC$ 1.03MC$ 1.59M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -710.00KC$ -120.00KC$ -1.64MC$ -808.00KC$ -1.33M
Total LiabilitiesC$ 1.50MC$ 603.00KC$ 1.27MC$ 1.87MC$ 674.00K
Stockholders EquityC$ -851.00KC$ -259.00KC$ 622.00KC$ -844.00KC$ 913.00K
Cash Flow-
Free Cash FlowC$ -1.13MC$ -1.49MC$ -1.84MC$ -1.54MC$ -4.00M
Operating Cash FlowC$ -1.13MC$ -1.49MC$ -1.83MC$ -1.54MC$ -3.99M
Investing Cash Flow--C$ -12.00KC$ 4.00KC$ -9.00K
Financing Cash FlowC$ 1.72MC$ 1.00KC$ 2.69MC$ 997.00KC$ 2.09M
Currency in CAD

Helix BioPharma Earnings and Revenue History

Helix BioPharma Debt to Assets

Helix BioPharma Cash Flow

Helix BioPharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis